These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3282129)

  • 1. Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies.
    de Rie MA; Zeijlemaker WP; von dem Borne AE
    Leuk Res; 1988; 12(2):135-41. PubMed ID: 3282129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory role of CD19 molecules in B-cell activation and differentiation.
    de Rie MA; Schumacher TN; van Schijndel GM; van Lier RA; Miedema F
    Cell Immunol; 1989 Feb; 118(2):368-81. PubMed ID: 2463100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
    Hooijberg E; van den Berk PC; Sein JJ; Wijdenes J; Hart AA; de Boer RW; Melief CJ; Hekman A
    Cancer Res; 1995 Feb; 55(4):840-6. PubMed ID: 7531616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody.
    Vervoordeldonk SF; Merle PA; van Leeuwen EF; van der Schoot CE; von dem Borne AE; Slaper-Cortenbach IC
    Blood; 1994 Mar; 83(6):1632-9. PubMed ID: 7510146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
    Ma D; McDevitt MR; Barendswaard E; Lai L; Curcio MJ; Pellegrini V; Brechbiel MW; Scheinberg DA
    Leukemia; 2002 Jan; 16(1):60-6. PubMed ID: 11840264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model.
    Vuist WM; v Buitenen F; de Rie MA; Hekman A; Rümke P; Melief CJ
    Cancer Res; 1989 Jul; 49(14):3783-8. PubMed ID: 2472198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.
    Press OW; Farr AG; Borroz KI; Anderson SK; Martin PJ
    Cancer Res; 1989 Sep; 49(17):4906-12. PubMed ID: 2667754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
    Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-induced antigenic modulation is antigen dependent: characterization of 22 proteins on a malignant human B cell line.
    Pesando JM; Hoffman P; Abed M
    J Immunol; 1986 Dec; 137(11):3689-95. PubMed ID: 3491146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antitumor activity of a chimeric anti-CD19 antibody.
    Pietersz GA; Wenjun L; Sutton VR; Burgess J; McKenzie IF; Zola H; Trapani JA
    Cancer Immunol Immunother; 1995 Jul; 41(1):53-60. PubMed ID: 7543822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies.
    Li JL; Shen GL; Ghetie MA; May RD; Till M; Ghetie V; Uhr JW; Janossy G; Thorpe PE; Amlot P
    Cell Immunol; 1989 Jan; 118(1):85-99. PubMed ID: 2463099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
    Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
    J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Internalization of tumor associated antigen on human lung adenocarcinoma cell line SPC-A-1 by McAb LC-1].
    Xie W; Zhang RX; Ge XR
    Shi Yan Sheng Wu Xue Bao; 1996 Sep; 29(3):207-19. PubMed ID: 9639808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.
    Bonardi MA; French RR; Amlot P; Gromo G; Modena D; Glennie MJ
    Cancer Res; 1993 Jul; 53(13):3015-21. PubMed ID: 7686448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human malignant B cells.
    Pulczynski S
    Leuk Lymphoma; 1994 Oct; 15(3-4):243-52. PubMed ID: 7532507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice.
    Ghetie MA; Richardson J; Tucker T; Jones D; Uhr JW; Vitetta ES
    Int J Cancer; 1990 Mar; 45(3):481-5. PubMed ID: 2307538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective killing of normal and neoplastic human B cells with anti-CD19- and anti-CD22-ricin A chain immunotoxins.
    May RD; Vitetta ES; Moldenhauer G; Dörken B
    Cancer Drug Deliv; 1986; 3(4):261-72. PubMed ID: 2436739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody.
    Vallera DA; Elson M; Brechbiel MW; Dusenbery KE; Burns LJ; Jaszcz WB; Ramsay NK; Panoskaltsis-Mortar A; Kuroki DW; Wagner JE; Vitetta ES; Kersey JH
    Cancer Biother Radiopharm; 2004 Feb; 19(1):11-23. PubMed ID: 15068607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study.
    Pulczynski S; Boesen AM; Jensen OM
    Blood; 1993 Mar; 81(6):1549-57. PubMed ID: 7680920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms.
    Smith SH; Rigley KP; Callard RE
    Immunology; 1991 Jul; 73(3):293-7. PubMed ID: 1715315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.